Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanano Mizumoto
Observed name:
H. Mizumoto
Institution:
University of Tokyo Hospital
Observed institutions:
Gunma University,
University of Tokyo Hospital
ORCID:
0009-0003-3250-2486
Observed ORCID:
0009-0003-3250-2486
OpenAlex ID:
A5065136104
Roles of CytR, an anti-activator of cyclic-AMP receptor protein (CRP) on flagellar expression and virulence in uropathogenic Escherichia coli
2019
·
Hidetada Hirakawa
, Ayako Takita
, et al.
·
Biochemical and Biophysical Research Communications
·
13
36.25 Gy versus 40 Gy in five fractions of curative stereotactic body radiotherapy for prostate cancer: a propensity score-matched analysis
2026
·
Hideomi Yamashita
, Daichi Sugahara
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy
2026
·
D. Sugahara
, H. Yamashita
, et al.
·
Clinical Oncology
Diabetes mellitus as a potential risk factor for severe late toxicity after stereotactic body radiotherapy for prostate cancer: a large single-institution cohort study
2026
·
Daichi Sugahara
, Hideomi Yamashita
, et al.
·
Journal of Radiation Research
Show more works
View as search
Works count:
4
Citation count:
13
H-index:
1
I10-index:
1
Year
Topic
Type